EUVIMEDEUVIMED entdecken
Crossref

Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction

Ruifang Wang, Maosong Qiu, Lei Zhang, Meiju Sui, Long Xiao, Qiao Yu, Chaohui Ye, Shizhen Chen, Xin Zhou iD

Advanced Materials · 2023-12 · 35 (49)

DOI: 10.1002/adma.202306748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 27.10.2023. Verfasst von Ruifang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Phys…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite its remarkable clinical breakthroughs, immune checkpoint blockade (ICB) therapy remains limited by the insufficient immune response in the “cold” tumor. Nanozyme‐based antitumor catalysis is associated with precise immune activation in the tumor microenvironment (TME). In this study, a cascade‐augmented nanoimmunomodulator (CMZM) with multienzyme‐like activities, which includes superoxide dismutase (SOD), catalase (CAT), peroxidase (POD), and glutathione oxidase (GSHOx), that dissociates under an acidic and abundant GSH TME, is proposed for multimodal imaging‐guided chemodynamic therapy (CDT)/photodynamic therapy (PDT) enhanced immunotherapy. Vigorous multienzyme‐like activities can not only produce O 2 to alleviate hypoxia and promote the polarization of M2 to M1 macrophages, but also generate ROS (•OH and 1 O 2 ) and deplete GSH in the TME to expose necrotic cell fragments and reverse immunosuppressive TME by eliciting the maturation of dendritic cells and infiltration of cytotoxic T lymphocytes (CTLs) in tumors. Therefore, inhibitory effects on both primary and distant tumors are achieved through synergy with an α‐PD‐L1 blocking antibody. This cascade multienzyme‐based nanoplatform provides a smart strategy for highly efficient ICB immunotherapy against “cold” tumors by revising immunosuppressive TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsHumansReactive Oxygen SpeciesPeroxidaseHomeostasisImmunosuppressive AgentsTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

MRIenzymatic cascade reactionsimmunotherapytumor cell membraneα-PD-L1

Substanzen

Reactive Oxygen SpeciesPeroxidaseImmunosuppressive Agents

Autor:innen und Institutionen

  • State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Scie…
  • University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Optics Valley Laboratory, Hubei, 430074, P. R. China.

ORCID-Profile: Xin Zhou

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Hubei Provincial Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, R., Qiu, M., Zhang, L., Sui, M., Xiao, L., Yu, Q., Ye, C., Chen, S., & Zhou, X. (2023). Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction. Advanced Materials, 35(49). https://doi.org/10.1002/adma.202306748

Vancouver

Wang R, Qiu M, Zhang L, Sui M, Xiao L, Yu Q, et al. Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction. Advanced Materials. 2023;35(49). doi:10.1002/adma.202306748

BibTeX
@article{Wang2023,
  author = {Wang, Ruifang and Qiu, Maosong and Zhang, Lei and Sui, Meiju and Xiao, Long and Yu, Qiao and Ye, Chaohui and Chen, Shizhen and Zhou, Xin},
  title = {Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {49},
  doi = {10.1002/adma.202306748}
}
Kostenlos starten →